RecruitingNCT05978141

A Registry for People With T-cell Lymphoma

The T-cell Lymphoma Master Repository (TCLMR): A Prospective Databank of Patients With T-cell Lymphoma With Clinical Annotation and Matched Tumor Specimens

Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

1,000 participants

Start Date

Jul 27, 2023

Study Type

OBSERVATIONAL

Conditions

T-cell Lymphoma NK-Cell Lymphoma T-cell Prolymphocytic Leukemia T-cell Large Granular Lymphocytic Leukemia Chronic Lymphoproliferative Disorder of NK Cells Aggressive NK-cell Leukemia Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder)

Summary

The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.

Eligibility

Plain Language Summary

Simplified for easier understanding

This is a registry (data collection) study for people diagnosed with T-cell lymphoma or NK-cell lymphoma, which are rare cancers of the immune system. The registry collects tumor samples, treatment history, and outcomes to improve understanding of these diseases. **You may be eligible if...** - You have been diagnosed with a mature T-cell or NK-cell lymphoma (including types such as T-cell large granular lymphocytic leukemia, adult T-cell leukemia/lymphoma, peripheral T-cell lymphoma, or other subtypes as confirmed by biopsy) - You are willing to provide consent and a tumor biopsy sample (fresh or archival) **You may NOT be eligible if...** - You have not been confirmed to have one of the qualifying T-cell or NK-cell lymphoma subtypes - You are unable or unwilling to provide informed consent or a tissue sample Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEROptional Blood Sample and Nail Sample

Participants may provide optional research blood and nail samples for biobanking and future use

Locations(26)

City of Hope Cancer Center (Data collection only)

Duarte, California, United States

UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only)

San Diego, California, United States

University of California San Francisco (Data collection only)

San Francisco, California, United States

Stanford University Medical Center (Data collection only)

Stanford, California, United States

University of Colorado (Data Collection Only)

Aurora, Colorado, United States

Yale University (Data Collection Only)

New Haven, Connecticut, United States

University of Miami (Data Collection Only)

Miami, Florida, United States

Moffitt Cancer Center (Data Collection Only)

Tampa, Florida, United States

Emory University (Data Collection Only)

Atlanta, Georgia, United States

Northwestern Medicine (Data Collection)

Chicago, Illinois, United States

Massachusetts General Hospital (Data Collection Only)

Boston, Massachusetts, United States

Dana Farber Cancer Institute (Data Collection Only)

Boston, Massachusetts, United States

Mayo Clinic (Data Collection Only)

Rochester, Minnesota, United States

Washington University (Data Collection Only)

St Louis, Missouri, United States

University of Nebraska (Data collection only)

Omaha, Nebraska, United States

Memorial Sloan Kettering at Basking Ridge (All protocol activities)

Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (All protocol activities)

Middletown, New Jersey, United States

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities)

Commack, New York, United States

Memorial Sloan Kettering Westchester (All protocol activities)

Harrison, New York, United States

Weill Cornell Medical Center (Data Collection Only)

New York, New York, United States

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, New York, United States

Memorial Sloan Kettering Nassau (All protocol activities)

Uniondale, New York, United States

Ohio State University (Data Collection Only)

Columbus, Ohio, United States

University of Pennsylvania (Data Collection Only)

Philadelphia, Pennsylvania, United States

Thomas Jefferson University Hospital (Data collection only)

Philadelphia, Pennsylvania, United States

MD Anderson Cancer Center (Data Collection Only)

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05978141

Related Trials

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

NCT063903193 locations

A Registry for People With T-cell Lymphoma

Conditions

Summary

Eligibility

Plain Language Summary

Interventions

Locations(26)

Related Trials

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

CD4CAR for CD4+ Leukemia and Lymphoma

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

A Study of Enasidenib in People With T-Cell Lymphoma

A Study of Ruxolitinib and Duvelisib in People With Lymphoma